BRIEF published on 09/26/2025 at 14:50, 6 months 13 days ago EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
PRESS RELEASE published on 09/26/2025 at 14:45, 6 months 13 days ago enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRIEF published on 09/15/2025 at 14:50, 6 months 24 days ago EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRIEF published on 09/15/2025 at 14:50, 6 months 24 days ago EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
PRESS RELEASE published on 09/15/2025 at 14:45, 6 months 24 days ago enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRIEF published on 08/20/2025 at 13:05, 7 months 20 days ago EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRIEF published on 08/20/2025 at 13:05, 7 months 20 days ago EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
PRESS RELEASE published on 08/20/2025 at 13:00, 7 months 20 days ago enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRIEF published on 08/15/2025 at 15:26, 7 months 25 days ago EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRIEF published on 08/15/2025 at 15:26, 7 months 25 days ago EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Published on 04/10/2026 at 02:15, 2 hours 17 minutes ago Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Published on 04/10/2026 at 01:05, 3 hours 27 minutes ago Pathfinder Ventures Inc. Announces Tranche Closing of Financing and Extension of Private Placement
Published on 04/10/2026 at 00:00, 4 hours 32 minutes ago Redwood AI Announces Upgraded Cloud-Based Reactosphere Platform with Enhanced Security and Expanded Core Capabilities
Published on 04/09/2026 at 23:15, 5 hours 17 minutes ago Digi Power X Enters into Amended and Restated Sales Agreement
Published on 04/09/2026 at 22:00, 6 hours 32 minutes ago Invitation - First Quarter 2026 Trading Update Conference Call
Published on 04/09/2026 at 21:01, 7 hours 31 minutes ago GEVELOT S.A.: PRESS RELEASE CLOSING OF 2025 ACCOUNTS
Published on 04/09/2026 at 21:01, 7 hours 31 minutes ago GEVELOT S.A.: COMMUNIQUE ARRETE DES COMPTES 2025
Published on 04/09/2026 at 20:03, 8 hours 29 minutes ago Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:45, 9 hours 47 minutes ago EUROPLASMA: Tirage de 200 obligations convertibles en actions nouvelles pour un montant nominal de 1M€
Published on 04/09/2026 at 20:00, 8 hours 32 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 1er trimestre 2026
Published on 04/09/2026 at 18:35, 9 hours 57 minutes ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 30 avril 2026
Published on 04/09/2026 at 18:35, 9 hours 57 minutes ago Availability of proxy documents for the Combined General Meeting of April 30, 2026
